Dimensional Fund Advisors’s Intersect ENT, Inc XENT Stock Holding History

Dimensional Fund Advisors’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-47,480	Closed	-$1.33M	–	3582
2022 Q1	$1.33M	Sell	47,480 -430	-0.9%	-$11.8K	﹤0.01%	2925
2021 Q4	$1.31M	Hold	47,910	–	–	﹤0.01%	2959
2021 Q3	$1.3M	Sell	47,910 -48,686	-50%	-$1.2M	﹤0.01%	2983
2021 Q2	$1.65M	Sell	96,596 -2,561	-3%	-$47.9K	﹤0.01%	2921
2021 Q1	$2.07M	Sell	99,157 -5,090	-5%	-$117K	﹤0.01%	2846
2020 Q4	$2.39M	Sell	104,247 -2,707	-3%	-$51.5K	﹤0.01%	2760
2020 Q3	$1.74M	Sell	106,954 -2,259	-2%	-$40.9K	﹤0.01%	2780
2020 Q2	$1.48M	Buy	109,213 +86,047	+371%	+$1M	﹤0.01%	2841
2020 Q1	$275K	Buy	23,166 +300	+1%	+$6.65K	﹤0.01%	3160
2019 Q4	$569K	Hold	22,866	–	–	﹤0.01%	3116
2019 Q3	$389K	Buy	+22,866	New	+$416K	﹤0.01%	3182

Dimensional Fund Advisors's XENT Position: Q2 2022 in Review

Dimensional Fund Advisors sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 47,480 shares — an estimated $1.33M sold.

Dimensional Fund Advisors first reported a position in XENT in Q3 2019 and held it in 11 quarters. The position peaked at $2.39M in Q4 2020. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

Dimensional Fund Advisors reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
Dimensional Fund Advisors sold 47,480 Intersect ENT, Inc shares in Q2 2022, an estimated $1.33M.
Dimensional Fund Advisors first reported a position in Intersect ENT, Inc in Q3 2019 and held it in 11 quarters.
Dimensional Fund Advisors's Intersect ENT, Inc position peaked at $2.39M in Q4 2020.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Dimensional Fund Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.